News from spark therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:SCHS)

Apr 28, 2015, 16:52 ET

Spark Therapeutics and Clearside Biomedical Announce Exclusive Option to License Technology for Potentially Differentiated Delivery of Gene Therapy to the Eye

 Spark Therapeutics, Inc. (NASDAQ: ONCE) and Clearside Biomedical, Inc. announced today that they have entered into an option agreement under...

Feb 26, 2015, 08:00 ET

Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference

 Spark Therapeutics (NASDAQ: ONCE) announced today that members of its management team will participate in the Cowen and Company Health Care...

Feb 04, 2015, 13:00 ET

Spark Therapeutics Announces Closing of Its Initial Public Offering

 Spark Therapeutics (NASDAQ: ONCE) announced today the closing of its initial public offering of 8,050,000 shares of common stock at a public...

Jan 30, 2015, 07:00 ET

Spark Therapeutics Announces Pricing of Its Initial Public Offering

 Spark Therapeutics announced today the pricing of its initial public offering of 7,000,000 shares of common stock at a public offering price...

Jan 20, 2015, 08:00 ET

Spark Therapeutics Initiates Phase 1/2 Clinical Trial of SPK-CHM for Choroideremia, Expanding its Pipeline of Potential Treatments for Rare, Blinding Conditions

Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating, genetic diseases, announced today it has initiated...

Dec 31, 2014, 08:00 ET

Spark Therapeutics Files Registration Statement for Initial Public Offering

 Spark Therapeutics announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission...

Dec 16, 2014, 08:00 ET

Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer

 Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that it has...

Dec 08, 2014, 07:30 ET

Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.

Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that it has entered...

Nov 25, 2014, 08:30 ET

Spark Therapeutics Appoints Former Chief of U.S. Food and Drug Administration's Gene Therapy Branch as its Head of Regulatory Affairs

 Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating, genetic diseases, announced today the...

Nov 06, 2014, 09:30 ET

Spark Therapeutics Receives FDA Breakthrough Therapy Designation for Its Lead Product Candidate, SPK-RPE65

Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that its lead...

Jun 16, 2014, 08:30 ET

Spark Therapeutics Appoints Industry Leaders Lars Ekman and Vin Milano to Board of Directors

 Spark Therapeutics, a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today...

Jun 02, 2014, 14:34 ET

Spark Therapeutics Leadership to Present at Three Upcoming Healthcare Investor Conferences

 Spark Therapeutics, Inc., a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced...

May 27, 2014, 14:47 ET

Spark Therapeutics Raises $72.8 Million in Oversubscribed Financing

 Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of rare, debilitating diseases, today announced the...

May 19, 2014, 11:24 ET

Spark Therapeutics to Present at the American Society of Gene & Cell Therapy 2014 Annual Meeting

Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today that co-founder...

May 13, 2014, 09:08 ET

Spark Therapeutics Establishes Permanent Headquarters in West Philadelphia

 Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today that it...

Mar 25, 2014, 00:00 ET

Spark Therapeutics and Genable Technologies Announce Collaboration to Advance a Gene Therapy Treatment for a Rare Form of Retinitis Pigmentosa

Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to...

Feb 11, 2014, 08:15 ET

Spark Therapeutics Appoints Industry Leader Dr. Elliott Sigal, Former Executive Vice President and Chief Scientific Officer of Bristol-Myers Squibb, to Board of Directors

 Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today the...

Jan 21, 2014, 08:30 ET

Spark Therapeutics Names Dr. Rogerio Vivaldi to Board of Directors

Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today that it...

Jan 14, 2014, 10:07 ET

Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness

Spark Therapeutics, a late-stage gene therapy company, has reached its patient recruitment goal for its most advanced clinical program, a...

Jan 09, 2014, 09:09 ET

Spark Therapeutics Expands Leadership Team to Support Development and Commercialization of its Late-Stage Gene Therapy Pipeline

 Spark Therapeutics, a late-stage, fully integrated company developing gene-based medicines for a wide range of debilitating diseases,...